Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 4 | 6 |
| 1997 | 0 | 6 | 6 |
| 1998 | 1 | 6 | 7 |
| 1999 | 1 | 0 | 1 |
| 2000 | 5 | 7 | 12 |
| 2001 | 1 | 14 | 15 |
| 2002 | 4 | 4 | 8 |
| 2003 | 4 | 8 | 12 |
| 2004 | 4 | 11 | 15 |
| 2005 | 6 | 10 | 16 |
| 2006 | 9 | 12 | 21 |
| 2007 | 12 | 7 | 19 |
| 2008 | 12 | 5 | 17 |
| 2009 | 9 | 15 | 24 |
| 2010 | 18 | 23 | 41 |
| 2011 | 9 | 18 | 27 |
| 2012 | 11 | 5 | 16 |
| 2013 | 19 | 17 | 36 |
| 2014 | 22 | 13 | 35 |
| 2015 | 22 | 17 | 39 |
| 2016 | 19 | 14 | 33 |
| 2017 | 23 | 18 | 41 |
| 2018 | 22 | 25 | 47 |
| 2019 | 20 | 22 | 42 |
| 2020 | 24 | 28 | 52 |
| 2021 | 12 | 42 | 54 |
| 2022 | 6 | 52 | 58 |
| 2023 | 2 | 46 | 48 |
| 2024 | 23 | 26 | 49 |
| 2025 | 36 | 13 | 49 |
| 2026 | 11 | 3 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Juvenile nasopharyngeal angiofibroma: nationwide study on incidence, diagnosis, treatment, and recurrence. Rhinology. 2026 Jun 01; 64(3):405-414.
-
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026 Apr 30; 147(18):2041-2052.
-
Local Control and Survival Outcomes in Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: The Mayo Clinic Experience. J Pediatr Hematol Oncol. 2026 Aug 01; 48(6):261-269.
-
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol. 2026 Apr 17; 177(3).
-
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients. Acta Neurochir (Wien). 2026 04 06; 168(1).
-
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors. Pediatr Blood Cancer. 2026 May; 73(5):e70199.
-
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2026 May; 73(5):e70195.
-
Sentinel lymph node status and oncological outcomes of high-risk and low-risk cutaneous primary melanoma. World J Surg Oncol. 2026 Mar 13; 24(1).
-
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma. J Neurooncol. 2026 Mar 11; 177(1).
-
PD-L1 positivity predicts a unique hyperaggressive tumor group within MenG C meningiomas. JNCI Cancer Spectr. 2026 Mar 03; 10(2).